Tyra Biosciences
$28.65
7
+$3.79+15.25% 20:00 Today
+$0.55+1.92%22:15After hours
Statistics
Day High
29.55
Day Low
24.51
52W High
40.65
52W Low
11.7
Volume
1,864,290
Avg. Volume
746,168
Mkt Cap
1.71B
P/E Ratio
-
Dividend Yield
-
Dividend
-
Upcoming
Earnings
11NovExpected
Q3 2024
Q1 2025
Q2 2025
Q3 2025
Q1 2026
Q2 2026
Next
-0.69
-0.59
-0.5
-0.4
Expected EPS
-0.689286
Actual EPS
N/A
Financials
-Profit Margin
Unprofitable0Revenue
-119.95MNet Income
Analyst Ratings
50.50Average Price Target
The highest estimate is 56.00.
From 7 ratings within the last 6 months. This is not an investment recommendation.
From 7 ratings within the last 6 months. This is not an investment recommendation.
Buy 86%
Hold 14%
Sell 0%
People Also Follow
This list is based on the watchlists of people on Stock Events who follow TYRA. It's not an investment recommendation.
Competitors
This list is an analysis based on recent market events. It's not an investment recommendation.
CRISPR Therapeutics
CRSP
Mkt Cap5.58B
Editas Medicine
EDIT
Mkt Cap485.31M
Intellia Therapeutics
NTLA
Mkt Cap1.8B
Beam Therapeutics
BEAM
Mkt Cap3.03B
Allogene Therapeutics
ALLO
Mkt Cap697.89M
Fate Therapeutics
FATE
Mkt Cap291.16M
Novartis
NVS
Mkt Cap292.35B
Gilead Sciences
GILD
Mkt Cap180.64B
About
Tyra Biosciences Inc is a clinical-stage biotechnology company focused on developing next-generation precision medicines for large opportunities in targeted oncology and genetically defined conditions, harnessing the power of Fibroblast Growth Factor Receptor (FGFR) biology. The company's in-house precision medicine platform, SNAP, enables rapid and precise drug design through iterative molecular SNAPshots that help to design and predict which product candidates may demonstrate the highest potency, selectivity, and tolerability in the clinic. The various drug candidates in the company's product pipeline are FGFR3, FGFR4/3, and FGFR1/2/3: three clinical-stage, novel small molecules designed to overcome the toxicity and resistance liabilities of first-generation pan-FGFR inhibitors.
Show more...
CEO
Todd Harris
Employees
87
Country
United States
ISIN
US90240B1061
Listings
0 Comments
Share your thoughts
FAQ
What is Tyra Biosciences stock price today?▼
The current price of TYRA is $28.65 USD — it has increased by +15.25% in the past 24 hours. Watch Tyra Biosciences stock price performance more closely on the chart.
What is Tyra Biosciences stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on XNAS exchange Tyra Biosciences stocks are traded under the ticker TYRA.
Is Tyra Biosciences stock price growing?▼
TYRA stock has risen by +14.88% compared to the previous week, the month change is a -11.93% fall, over the last year Tyra Biosciences has showed a +136% increase.
What is Tyra Biosciences market cap?▼
Today Tyra Biosciences has the market capitalization of 1.71B
When is the next Tyra Biosciences earnings date?▼
Tyra Biosciences is going to release the next earnings report on November 11, 2026.
What were Tyra Biosciences earnings last quarter?▼
TYRA earnings for the last quarter are -0.69 USD per share, whereas the estimation was -0.65 USD resulting in a -6.17% surprise. The estimated earnings for the next quarter are N/A USD per share.
What is Tyra Biosciences revenue for the last year?▼
Tyra Biosciences revenue for the last year amounts to 0 USD.
What is Tyra Biosciences net income for the last year?▼
TYRA net income for the last year is -119.95M USD.
How many employees does Tyra Biosciences have?▼
As of September 04, 2026, the company has 87 employees.
In which sector is Tyra Biosciences located?▼
Tyra Biosciences operates in the Health & Wellness sector.
When did Tyra Biosciences complete a stock split?▼
Tyra Biosciences has not had any recent stock splits.
Where is Tyra Biosciences headquartered?▼
Tyra Biosciences is headquartered in CARLSBAD, United States.